Research Peptides

Livagen

Livagen is a trade-style catalog label with two injectable rows, 10 and 20, and a published floor of $3.06. The label and numerical rows do not state a molecular identity, constituent profile or manufacturer. They are therefore useful only to select the requested line; the quote must supply the identity basis, supplied form and allocated-lot records. This listing is for research procurement only.

Procurement record

Catalog identityLivagen
Catalog categoryResearch Peptides
Price-list identityLivagen
SKU / form rows10 / Injectable; 20 / Injectable
Specification and purityConfirm the offered specification, method, acceptance criterion and allocated-lot result in the quotation. No sitewide purity guarantee is made.
Documents and handlingConfirm available batch documents, storage, packaging, transit conditions and destination requirements for the exact supplied form.

Checks before approving Livagen

  • Match the product name, manufacturer, sequence or analogue, salt/form and 10 / Injectable to the quotation.
  • Confirm the unit represented by the SKU row and keep it separate from any dosage or administration decision.
  • Request the allocated-lot identity method, specification, acceptance criteria and available batch results.
  • Confirm storage, packaging, dispatch estimate, importer obligations and destination-specific delivery terms in writing.
  • Compare any literature reference with the exact supplied material; a paper does not prove supplier-batch equivalence.

Wholesale pricing for Livagen

Wholesale from $3.06

Price-list tiers apply when the order reaches 100+ total units. Each tier is based on the quantity of the individual SKU; smaller orders are quoted separately.

Published price-list tiers

Livagen published price-list tiers
SKU / form10–24 units of this SKU25–49 units of this SKU50+ units of this SKU
10 / Injectable$4.08$3.57$3.06
20 / Injectable$6.80$5.95$5.10

The labels above reproduce the current price-list entries. They are not dosage instructions. Confirm the unit, exact supplied form, allocated lot, analytical package and availability in the quote.

Evidence boundary for Livagen

PubMed: Livagen record (PMID 12533768) uses the Livagen name in a synthetic-peptide study. It supports terminology and study-scope resolution only; it does not establish the composition, supplier identity or performance of either catalog row.

Questions about Livagen

Livagen is a research peptides catalog listing. Confirm the exact manufacturer, composition or sequence, supplied form and allocated-lot identity in the quotation.

The table shows the current published tiers for 2 matched SKU/form rows. The quote still confirms the allocated lot, availability, currency, destination terms and any rows that are price-on-request.

A purity figure is meaningful only when the method, acceptance criterion and allocated-lot result are identified. The quotation confirms what documentation is available; this page makes no universal purity guarantee.

Request the product identity and supplied form, specification, method and acceptance criteria, allocated-lot results, available COA or analytical documents, storage/handling instructions and destination-specific delivery terms.

No. The linked reference provides identity or terminology context only; it does not identify or verify the material in the selected catalog row. Neither a publication nor a database record proves supplier-batch equivalence, suitability, safety or dosing.

This catalog is for research procurement. It does not provide medical, veterinary, dosing, administration or treatment instructions. Check the laws and institutional requirements that apply to the intended work.

Related Research Peptides

Request Livagen Price List